PIPELINE WATCH: Eight Approvals, Seven Filings And Three Launches
Executive Summary
This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.
| Table |
|---|
Advertisement
Topics
- Subjects
- Research & Development
- Pipeline Watch
- Approvals
- Industries
- BioPharmaceutical
Related Companies
- AstraZeneca PLC
- Bausch Health Companies Inc.
- Progenics Pharmaceuticals Inc.
- Celgene Corp.
- Janssen Inc.
- Pharmacyclics Inc.
- Eisai Co. Ltd.
- Arena Pharmaceuticals Inc.
- CSL Behring
- Janssen Pharmaceuticals Inc.
- Mylan Pharmaceuticals Inc.
- Biocon Ltd.
- Amgen Inc.
- Ipsen
- Lexicon Pharmaceuticals Inc.
- Merck KGaA
- Samsung Bioepis Co. Ltd.
- Samsung BioLogics
- Biogen
- Merck & Co. Inc.
- Bristol-Myers Squibb Co.
- Incyte Corp.
- Eli Lilly & Co.
- Novartis AG
- Xoma Corp.
- Alcobra Ltd.
- Advaxis Inc.
- Cerulean Pharma Inc.
- ProQR Therapeutics NV
- Auris Medical Holding AG
- Spark Therapeutics Inc.
- Pfizer Inc.
- AveXis Inc.
- Elite Pharmaceuticals Inc.
- Puma Biotechnology Inc.
- Newron Pharmaceuticals SPA
- Merck KGaA
- CSL Ltd.
- Valneva SE
- Norgine BV
- Takeda Pharmaceutical Co. Ltd.
- Fujifilm Pharma Co. Ltd.
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SC096960
Ask The Analyst
Please Note: Click here for more information on the Ask the Analyst service.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
SC096960
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.